Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease - Sorbonne Université
Journal Articles Journal of the American Medical Association Year : 2017

Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease

Domains

Life Sciences [q-bio]

Gestionnaire HAL 4 Sorbonne Université  : Connect in order to contact the contributor

https://hal.sorbonne-universite.fr/hal-03703936

Submitted on : Friday, June 24, 2022-2:13:11 PM

Last modification on : Friday, April 19, 2024-11:59:08 AM

Consult the full text

Dates and versions

hal-03703936 , version 1 (24-06-2022)

Identifiers

Cite

Magali Lemaitre, Julien Kirchgesner, Annie Rudnichi, Fabrice Carrat, Mahmoud Zureik, et al.. Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease. Journal of the American Medical Association, 2017, 318 (17), pp.1679. ⟨10.1001/jama.2017.16071⟩. ⟨hal-03703936⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

INSERM UPMC IPLESP UNIV-PARIS-SACLAY SORBONNE-UNIVERSITE SU-MEDECINE
29 View
0 Download

Altmetric

Share

More